Together VLE and APC will apply the latest innovations in process, analytical and manufacturing science to dramatically reduce time to market for the world’s newest and most advanced medicines. In parallel, VLE will open an additional bespoke 80,000 sq. ft. …

Decades of breakthroughs in manufacturing, analytical and process development have equipped us to identify and fill a critical gap in today's CDMO landscape. Delighted to announce The …

We activated the APC / VLE Medicine Accelerator strategy and we got the price per dose down to a fraction, per dose, of the original cost – and we can make material that will go from 10s of people to like 2000 people.

2024年1月9日 · The Medicine Accelerator, the Irish Multinational group responsible for breakthrough pharma process research and development (APC) and Manufacture (VLE), today announce a groundbreaking expansion that involves the creation of 300 new R&D jobs and a €100M capital expansion to form a globally unique Medicine Accelerator Campus in …

Through the Covid-19 Products Scheme, Enterprise Ireland has supported APC’s new research facility for the accelerated process development of vaccine candidates and new medicines. Enterprise Ireland is also providing strategic funding for APC’s sister company VLE to manufacture advanced therapeutics and vaccines, including Covid-19 vaccines.

With APC at the helm of process development, VLE extends the value chain for our clients by accelerating GMP manufacturing through all phases of clinical trials. We’re reducing costs and shortening timelines while optimizing manufacturing for …

Explore our 130,000 sq ft campus in development, the largest R&D site in the biopharma sector in Ireland and the expanded home for The Medicine Accelerator (APC & VLE Therapeutics), will integrate the latest developments in scientific research, AI, neural networks and scientifically led manufacturing activities.

2024年8月20日 · APC and VLE Therapeutics are Irish multinational pharmaceutical businesses aiming to accelerate the development and manufacture of medicines. Around 80% export-driven, the group partners with some of the world’s largest pharmaceutical companies. Founded in 2011, APC and VLE Therapeutics have grown rapidly in the past decade. The group has ...

2024年3月5日 · APC and VLE Therapeutics, the Irish multinational group responsible for breakthrough pharma process research and development (R&D) and manufacture, has today announced a groundbreaking expansion that involves a €100 million capital expansion to form a globally unique Medicine Accelerator Campus in Cherrywood, Dublin, and the creation of 300 R ...

At VLE, we deliver pragmatic solutions all along your CMC journey—all under one roof. Now, nothing stands in the way of your medicine. Based on your process needs, we call on our specialized process development arm, APC, to adapt and refine your existing process in direct collaboration with our GMP team.